Humana Inc. (HUM) Position Raised by Teachers Advisors LLC
Teachers Advisors LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 31.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 630,835 shares of the insurance provider’s stock after purchasing an additional 151,603 shares during the quarter. Teachers Advisors LLC owned 0.44% of Humana worth $151,792,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of HUM. Empirical Finance LLC lifted its holdings in shares of Humana by 2.0% in the second quarter. Empirical Finance LLC now owns 10,742 shares of the insurance provider’s stock worth $2,585,000 after acquiring an additional 210 shares during the last quarter. Stephens Inc. AR bought a new position in shares of Humana in the second quarter worth about $230,000. HGK Asset Management Inc. bought a new position in shares of Humana in the second quarter worth about $229,000. Riverhead Capital Management LLC lifted its holdings in shares of Humana by 825.4% in the second quarter. Riverhead Capital Management LLC now owns 15,500 shares of the insurance provider’s stock worth $3,730,000 after acquiring an additional 13,825 shares during the last quarter. Finally, AJO LP bought a new position in shares of Humana in the second quarter worth about $1,352,000. 95.14% of the stock is owned by institutional investors and hedge funds.
In other news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now directly owns 14,258 shares of the company’s stock, valued at $3,421,920. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $259.00, for a total value of $2,534,574.00. Following the transaction, the insider now directly owns 18,042 shares in the company, valued at $4,672,878. The disclosure for this sale can be found here. Insiders have sold 60,566 shares of company stock worth $15,326,746 over the last three months. Insiders own 0.80% of the company’s stock.
HUM has been the subject of a number of research reports. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a report on Thursday, June 1st. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a report on Friday, June 9th. BidaskClub raised shares of Humana from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Citigroup Inc. initiated coverage on shares of Humana in a report on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price for the company. Finally, Bank of America Corporation increased their target price on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, July 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $244.35.
COPYRIGHT VIOLATION NOTICE: “Humana Inc. (HUM) Position Raised by Teachers Advisors LLC” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/12/humana-inc-hum-position-raised-by-teachers-advisors-llc.html.
Humana Inc. (NYSE:HUM) traded down 0.38% during mid-day trading on Tuesday, reaching $256.22. 203,314 shares of the company’s stock were exchanged. The stock has a market cap of $37.03 billion, a price-to-earnings ratio of 21.08 and a beta of 0.87. The stock has a 50-day moving average of $247.99 and a 200-day moving average of $230.38. Humana Inc. has a one year low of $163.50 and a one year high of $259.47.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the firm earned $2.30 earnings per share. On average, equities research analysts anticipate that Humana Inc. will post $11.55 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.62%. Humana’s dividend payout ratio (DPR) is presently 13.06%.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.